- Home
- ANIK vs PRQR Comparison
ANIK vs PRQR Comparison
Compare ANIK & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- PRQR
- Stock Information
- Founded
- ANIK 1983
- PRQR 2012
- Country
- ANIK United States
- PRQR Netherlands
- Employees
- ANIK N/A
- PRQR N/A
- Industry
- ANIK Medical/Dental Instruments
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- ANIK Health Care
- PRQR Health Care
- Exchange
- ANIK Nasdaq
- PRQR Nasdaq
- Market Cap
- ANIK 196.6M
- PRQR 179.1M
- IPO Year
- ANIK 1993
- PRQR 2014
- Fundamental
- Price
- ANIK $10.63
- PRQR $2.04
- Analyst Decision
- ANIK Buy
- PRQR Strong Buy
- Analyst Count
- ANIK 1
- PRQR 8
- Target Price
- ANIK $19.00
- PRQR $8.88
- AVG Volume (30 Days)
- ANIK 66.2K
- PRQR 355.0K
- Earning Date
- ANIK 08-07-2025
- PRQR 08-07-2025
- Dividend Yield
- ANIK N/A
- PRQR N/A
- EPS Growth
- ANIK N/A
- PRQR N/A
- EPS
- ANIK N/A
- PRQR N/A
- Revenue
- ANIK $117,053,000.00
- PRQR $21,212,711.00
- Revenue This Year
- ANIK N/A
- PRQR N/A
- Revenue Next Year
- ANIK $9.70
- PRQR N/A
- P/E Ratio
- ANIK N/A
- PRQR N/A
- Revenue Growth
- ANIK 4.61
- PRQR 85.91
- 52 Week Low
- ANIK $10.47
- PRQR $1.07
- 52 Week High
- ANIK $29.12
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- ANIK 39.60
- PRQR 71.54
- Support Level
- ANIK $10.47
- PRQR $1.89
- Resistance Level
- ANIK $11.43
- PRQR $2.20
- Average True Range (ATR)
- ANIK 0.41
- PRQR 0.11
- MACD
- ANIK 0.07
- PRQR 0.02
- Stochastic Oscillator
- ANIK 27.48
- PRQR 90.70
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.